CMS

News

PhRMA is challenging the Trump administration's GLOBE model for Most-Favoured Nation pricing in Medicare Part B in a US district court.

News

CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.

Market Access

Hogan Lovells partner Alice Valder Curran returned to elucidate some of the finer points of the latest communication from CMS.

News

Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.

News

CMS has extended the deadline for its Medicaid drug pricing pilot, GENEROUS, to "provide interested drug manufacturers more opportunity to join."

News

The US federal government has named the next 15 big-selling medicines that will be subject to Medicare pricing negotiations.